Annotated Medicine and Device Lists


Haiti. National List of Essential Medicines

01. Anesthetics
    01.01 General anesthetics and oxygen
      01.01.01 Inhaled medications 01.01.2 Injectable drugs
        Medicine Pharmaceutical form type Composition Observation
        ketamine Injection 50 mg (as hydrochloride)/mL in 10-mL vial
        thiopental Powder for injection 1 g
    01.02. Local Anesthetics 01.03. Anesthetic premedication and sedation for short- term procedures 01.04. Medical Gas
      Medicine Pharmaceutical form type Composition Observation
      oxygen Inhalation (medicine gas) N/A
02. Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Antigout
03. Antiallergic/ Anti-anaphylactic
04. Antidotes/ Poisoning Treatments
05. Antiepileptics/ Anticonvulsants
06. Anti-infectives
07. Antimigraine
08. Antineoplastic- Immunosupressants
09. Antiparkinsons
10. Drugs used in Hematology
11. Blood Derivatives and Plasma Substitutes
    11.01 Plasma substitutes 11.02. Plasma-derived drugs
      *All medicinal products derived from human plasma must comply with WHO requirements.
      11.02.01 Human immunoglobulins 11.02.02 Coagulation factors
        Medicine Pharmaceutical form type Composition Observation

        Complementary list

        Medicine Pharmaceutical form type Composition Observation
        factor VIII Solution for injection 500 UI
12. Cardiovascular Drugs
13. Drugs Used in Dermatology
14. Diagnostic Products
    14.01. In Ophthalmology
      Medicine Pharmaceutical form type Composition Observation
      fluorescein Solution (eye drops) 1%
      tropicamide Solution (eye drops) 0.5%
    14.02. Contrast Products
15. Disinfectants and Antiseptics
16. Diuretics
17. Medicines Indicated in Gastroenterology
18. Hormones, Other Drugs Indicated in Endocrinology and Contraceptives
    18.01 Adrenal Hormone Substitutes and Synthetics 18.02 Androgens (see complementary list)
      Medicine Pharmaceutical form type Composition Observation

      Complementary list

      Medicine Pharmaceutical form type Composition Observation
      testosterone Injection 200 mg (enanthate) in 1-mL ampoule
    18.03. Contraceptives
      18.03.01 Oral hormonal contraceptives 18.03.02 Injectable hormonal contraceptives 18.03.03 Intrauterine devices 18.03.04 Local contraception
        Medicine Pharmaceutical form type Composition Observation
        condoms N/A N/A
      18.03.05 Implantable contraceptives
        Medicine Pharmaceutical form type Composition Observation
        levonorgestrel-releasing implant N/A Two-rod levonorgestrel-releasing implant, each rod containing 75 mg of levonorgestrel (150 mg total)
      18.03.06 Intravaginal contraceptives (Not used in the maternal health priority program)
        Medicine Pharmaceutical form type Composition Observation
    18.04 Antidiabetics and other drugs used in diabetes 18.05 Ovulation inducers (see complementary list)
      Medicine Pharmaceutical form type Composition Observation

      Complementary list

      Medicine Pharmaceutical form type Composition Observation
      clomifene Tablet 50 mg (citrate)
    18.06 Progestins (Not available in MSPP Family Planning (FP) program list)
      Medicine Pharmaceutical form type Composition Observation
    18.07. Thyroid hormones / Synthetic anti-thyroid drugs
19. Immunological Preparations
20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors
21. Preparations for Ophthalmology
    21.01. Anti-infectives 21.02. Anti-inflammatory steroids
      Medicine Pharmaceutical form type Composition Observation
      prednisolone Solution (eye drops) 0.5%
    21.03. Local anesthetics
      Medicine Pharmaceutical form type Composition Observation
      tetracaine Solution (eye drops) 0.5% (hydrochloride)
    21.04. Miotics and Antiglaucoma
      Medicine Pharmaceutical form type Composition Observation
      acetazolamide Tablet 250 mg
      latanoprost Solution (eye drops) 0.005%
      pilocarpine Solution (eye drops) 2% (hydrochloride)
      pilocarpine Solution (eye drops) 4% (hydrochloride or nitrate)
      timolol Solution (eye drops) 0.25% (maleate)
      timolol Solution (eye drops) 0.5 %

      Complementary list

      Medicine Pharmaceutical form type Composition Observation
      epinephrine (adrenaline) Solution (eye drops) 2% (as hydrochloride)
    21.05. Mydriatics
      Medicine Pharmaceutical form type Composition Observation
      atropine Solution (eye drops) 0.1% (sulfate)
      atropine Solution (eye drops) 0.5% (sulfate)
      atropine Solution (eye drops) 1% (sulfate)
    21.06. Anti-vascular endothelial growth factor preparations
      Medicine Pharmaceutical form type Composition Observation

      Complementary list

      Medicine Pharmaceutical form type Composition Observation
      bevacizumab Infusion 25mg/ml
22. Oxytocics and Antioxytocics
    22.01. Oxytocics
      Medicine Pharmaceutical form type Composition Observation
      ergometrine Injection 0,2 mg/ml
      oxytocin Injection 10 units/ml

      Complementary list

      Medicine Pharmaceutical form type Composition Observation
      misoprostol Tablet 200 mcg
      misoprostol Vaginal tablet 25 mcg
    22.02. Antioxytocics (tocolytics)
      Medicine Pharmaceutical form type Composition Observation
      nifedipine Immediate-release capsule 10 mg
23. Solutions for Peritoneal Dialysis
24. Drugs for Mental and Behavioral Problems
25. Medicines Indicated in Pneumology
26. Correction of Fluid and Electrolyte Disorders
27. Vitamins and Minerals
28. Medications for Nose, Ear and Throat Conditions
29. Medicines for Neonatal Care
    29.01 Medicines administered to newborns
      Medicine Pharmaceutical form type Composition Observation
      caffeine citrate Injection 20 mg/ml (equivalent to 10 mg caffeine base/ml)
      caffeine citrate Oral liquid 20 mg/ml (equivalent to 10 mg caffeine base/ml)
      chlorhexidine Solution 7.1% (digluconate)
      gentian violet Solution N/A

      Complementary list

      Medicine Pharmaceutical form type Composition Observation
      ibuprofen Solution for injection 5 mg/mL
      prostaglandin E Solution for injection Prostaglandin E1: 0.5 mg/ml in alcohol
      prostaglandin E Solution for injection Prostaglandin E2: 1 mg/ml
      surfactant Suspension for intratracheal instillation 25 mg/ml
      surfactant Suspension for intratracheal instillation 80 mg/ml
    29.02. Medicines administered to the mother
      Medicine Pharmaceutical form type Composition Observation
      dexamethasone Injection 4 mg/mL
30. Medications for Joint Disease
    30.01. Drugs used in treatment of gout
      Medicine Pharmaceutical form type Composition Observation
      allopurinol Tablet 100 mg
    30.02. Disease modifying agents used in rheumatoid arthritis 30.03. Juvenile Joint Disease